|
|
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
4-Dimethylaminoazobenzene |
CAS 60-11-7 | ||
C6H5NNC6H4N(CH3)2 |
RTECS BX7350000 | ||
|
Synonyms & Trade Names Butter yellow; DAB; p-Dimethylaminoazobenzene; N,N-Dimethyl-4-aminoazobenzene; Methyl yellow |
DOT ID & Guide |
||
Exposure
|
NIOSH REL: Ca See Appendix A | ||
| OSHA PEL: [1910.1015] See Appendix B | |||
| IDLH Ca [N.D.] See: IDLH INDEX | Conversion | ||
|
Physical Description Yellow, leaf-shaped crystals. |
|||
|
MW: 225.3 |
BP: Sublimes |
MLT: 237°F |
Sol: 0.001% |
|
VP: 0.0000003 mmHg (est.) |
IP: ? |
|
Sp.Gr: ? |
|
Fl.P: ? |
UEL: ? |
LEL: ? |
|
|
Incompatibilities & Reactivities None reported |
|||
|
Measurement Methods NIOSH P&CAM284 (II-4) See: NMAM or OSHA Methods |
|
Personal Protection & Sanitation (See protection) Skin: Prevent skin contact Eyes: Prevent eye contact Wash skin: When contaminated/Daily Remove: When wet or contaminated Change: Daily Provide: Eyewash, Quick drench |
First Aid (See procedures) Eye: Irrigate immediately Skin: Soap wash immediately Breathing: Respiratory support Swallow: Medical attention immediately |
|
Important additional information about respirator selection Respirator Recommendations (See Appendix E) NIOSH At concentrations above the NIOSH REL, or where there is no REL, at any detectable concentration. (APF = 10,000) Any self-contained breathing apparatus that has a full facepiece and is operated in a pressure-demand or other positive-pressure mode (APF = 10,000) Any supplied-air respirator that has a full facepiece and is operated in a pressure-demand or other positive-pressure mode in combination with an auxiliary self-contained positive-pressure breathing apparatus Escape: (APF = 50) Any air-purifying, full-facepiece respirator with an N100, R100, or P100 filter. Click here for information on selection of N, R, or P filters./Any appropriate escape-type, self-contained breathing apparatus |
|
| Exposure Routes inhalation, skin absorption, ingestion, skin and/or eye contact | |
| Symptoms Enlarged liver; liver, kidney disturbance; contact dermatitis; cough, wheezing, dyspnea (breathing difficulty); bloody sputum; bronchial secretions; frequent urination, hematuria (blood in the urine), dysuria; [potential occupational carcinogen] | |
|
Target Organs
Skin, respiratory system, liver, kidneys, bladder Cancer Site [in animals: liver & bladder tumors] |
|
| See also: INTRODUCTION See MEDICAL TESTS: 0081 |